Crewe Advisors LLC
- SEC CIK
- 0001730033
- Latest filing
- Jul 23, 2026
VKTX holding history
Viking Therapeutics, Inc. in every 13F filed by Crewe Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VKTX overviewAll 13F holders of VKTXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −8,322−100.0% | Sold out | Holders |
| Q3 2025 | 8,322 | $218.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 8,322 | $220.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 8,322 | $201.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 8,322 | $334.9K | <0.1% | −8,044−49.2% | Reduced | Holders |
| Q3 2024 | 16,366 | $1.04M | 0.1% | +16,366 | New | Holders |